Valuation Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 07:30:46 25/09/26 pm AEST			5-day change	1st Jan Change
4.812 ^EUR	-1.80%		0.00%	-30.00%

09/09	Clinuvel Pharmaceuticals Ltd Completes Development Of Zerokin Single-Use Administration Device For Controlled-Release Formulations	CI
08/09	Clinuvel Pharmaceuticals Completes Development of Proprietary Drug Delivery Device	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	733.7	883.5	769.8	520.3	518.4	416.5	-	-
Change	-	20.4%	-12.87%	-32.41%	-0.36%	-19.65%	-	-
Enterprise Value (EV) ¹	612.2	726.6	585.9	296.2	309.1	132.6	99.23	59.78
Change	-	18.69%	-19.37%	-49.45%	4.37%	-57.09%	-25.19%	-39.76%
P/E	36.8x	30.3x	22x	14.5x	15.4x	11.6x	11x	7.68x
PBR	5.84x	5.37x	3.79x	2.17x	1.91x	1.36x	1.23x	1.07x
PEG	-	0.6x	1.2x	5.06x	-2.21x	1.79x	1.97x	0.2x
Capitalization / Revenue	11.2x	11.3x	8.73x	5.48x	5.51x	4.39x	4.04x	3.03x
EV / Revenue	9.32x	9.28x	6.64x	3.12x	3.29x	1.4x	0.96x	0.44x
EV / EBITDA	16.4x	19.5x	12x	6.84x	8.09x	3.5x	2.37x	0.97x
EV / EBIT	16.7x	20x	12.3x	7.03x	8.31x	3.6x	2.44x	0.99x
EV / FCF	15.5x	20.2x	18.6x	7.26x	8.76x	3.62x	2.45x	1.03x
FCF Yield	6.44%	4.94%	5.37%	13.8%	11.4%	27.7%	40.8%	97.1%
Dividend per Share ²	0.04	0.05	0.05	0.05	0.05	0.0547	0.065	0.0913
Rate of return	0.27%	0.28%	0.33%	0.48%	0.49%	0.66%	0.79%	1.11%
EPS ²	0.403	0.591	0.698	0.718	0.668	0.7112	0.7508	1.076
Distribution rate	9.93%	8.46%	7.16%	6.96%	7.49%	7.69%	8.66%	8.49%
Net sales ¹	65.72	78.32	88.18	95.02	94.02	94.86	103	137.3
EBITDA ¹	37.44	37.2	48.95	43.3	38.2	37.94	41.81	61.94
EBIT ¹	36.68	36.41	47.81	42.12	37.21	36.85	40.62	60.47
Net income ¹	20.88	30.6	35.64	36.17	33.92	36.02	38.1	54.47
Net Debt ¹	-121.5	-156.8	-183.9	-224.1	-209.3	-283.9	-317.3	-356.8
Reference price ²	14.850	17.880	15.370	10.380	10.280	8.260	8.260	8.260
Nbr of stocks (in thousands)	49,410	49,410	50,083	50,124	50,428	50,428	-	-
Announcement Date	30/8/22	29/8/23	28/8/24	27/8/25	27/8/26	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	18.14x	4.26x	10.04x	0.49%	79.49B
MODERNA, INC.	-23.24x	35.29x	-22.91x	-.--%	77.78B
CSL LIMITED	20.69x	4.4x	13.62x	2.39%	60.16B
SAMSUNG BIOLOGICS CO.,LTD.	33.28x	11.32x	21.7x	-.--%	46.14B
UCB	21.17x	4.69x	13.35x	0.69%	45.93B
BIOGEN INC.	36.92x	3.68x	13.78x	-.--%	33.45B
INCYTE CORPORATION	55.53x	3.53x	27.38x	-.--%	25.22B
INNOVENT BIOLOGICS, INC.	63.4x	7.07x	42.3x	-.--%	22.15B
SWEDISH ORPHAN BIOVITRUM AB	22.85x	4.91x	12.79x	-.--%	15.25B
Average	27.64x	8.79x	14.67x	0.4%	45.06B
Weighted average by Cap.	19.17x	11.17x	9.21x	0.53%